Clinical Trial Update: Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) [Phase 1]

View source ↗

Summary

Phase 1/ Ib study evaluating hotspot TCR-T cell therapy with gene-engineered T cells for malignant epithelial neoplasms; the trial is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Epithelial Neoplasms

Drugs mentioned

• Hotspot TCR-T therapy (TCR-engineered T cells targeting hotspot epitopes)

Snippet

Sponsor: Providence Health & Services | Conditions: Malignant Epithelial Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING